0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Primary Antibody Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-27W7898
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Primary Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global Primary Antibody Market Research Report 2023

Code: QYRE-Auto-27W7898
Report
February 2023
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Primary Antibody Market

The global Primary Antibody market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Primary Antibody is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Primary Antibody is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Primary Antibody include Bio-Rad, Biorbyt, Abcam, Thermo Fisher Scientific, Creative Diagnostics, Novus Biologicals, SouthernBiotech, Boster Bio and OriGene, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Primary Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primary Antibody.
The Primary Antibody market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Primary Antibody market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Primary Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Bio-Rad
  • Biorbyt
  • Abcam
  • Thermo Fisher Scientific
  • Creative Diagnostics
  • Novus Biologicals
  • SouthernBiotech
  • Boster Bio
  • OriGene
  • Genscript Biotech
  • Proteintech
  • Roche Diagnostics
  • HyTest

Segment by Type

  • Monoclonal Antibodies
  • Polyclonal Antibody

Segment by Application

  • Hospital
  • Life Sciences
  • Laboratory

Consumption by Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Primary Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Primary Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Primary Antibody Market Report

Report MetricDetails
Report NameGlobal Primary Antibody Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Primary Antibody Market Overview
1.1 Product Overview and Scope of Primary Antibody
1.2 Primary Antibody Segment by Type
1.2.1 Global Primary Antibody Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibody
1.3 Primary Antibody Segment by Application
1.3.1 Global Primary Antibody Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Life Sciences
1.3.4 Laboratory
1.4 Global Primary Antibody Market Size Estimates and Forecasts
1.4.1 Global Primary Antibody Revenue 2018-2029
1.4.2 Global Primary Antibody Sales 2018-2029
1.4.3 Global Primary Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Primary Antibody Market Competition by Manufacturers
2.1 Global Primary Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global Primary Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Primary Antibody Average Price by Manufacturers (2018-2023)
2.4 Global Primary Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Primary Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Primary Antibody, Product Type & Application
2.7 Primary Antibody Market Competitive Situation and Trends
2.7.1 Primary Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Primary Antibody Players Market Share by Revenue
2.7.3 Global Primary Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Primary Antibody Retrospective Market Scenario by Region
3.1 Global Primary Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Primary Antibody Global Primary Antibody Sales by Region: 2018-2029
3.2.1 Global Primary Antibody Sales by Region: 2018-2023
3.2.2 Global Primary Antibody Sales by Region: 2024-2029
3.3 Global Primary Antibody Global Primary Antibody Revenue by Region: 2018-2029
3.3.1 Global Primary Antibody Revenue by Region: 2018-2023
3.3.2 Global Primary Antibody Revenue by Region: 2024-2029
3.4 North America Primary Antibody Market Facts & Figures by Country
3.4.1 North America Primary Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Primary Antibody Sales by Country (2018-2029)
3.4.3 North America Primary Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Primary Antibody Market Facts & Figures by Country
3.5.1 Europe Primary Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Primary Antibody Sales by Country (2018-2029)
3.5.3 Europe Primary Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Primary Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Primary Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Primary Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific Primary Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Primary Antibody Market Facts & Figures by Country
3.7.1 Latin America Primary Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Primary Antibody Sales by Country (2018-2029)
3.7.3 Latin America Primary Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Primary Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Primary Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Primary Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa Primary Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Primary Antibody Sales by Type (2018-2029)
4.1.1 Global Primary Antibody Sales by Type (2018-2023)
4.1.2 Global Primary Antibody Sales by Type (2024-2029)
4.1.3 Global Primary Antibody Sales Market Share by Type (2018-2029)
4.2 Global Primary Antibody Revenue by Type (2018-2029)
4.2.1 Global Primary Antibody Revenue by Type (2018-2023)
4.2.2 Global Primary Antibody Revenue by Type (2024-2029)
4.2.3 Global Primary Antibody Revenue Market Share by Type (2018-2029)
4.3 Global Primary Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global Primary Antibody Sales by Application (2018-2029)
5.1.1 Global Primary Antibody Sales by Application (2018-2023)
5.1.2 Global Primary Antibody Sales by Application (2024-2029)
5.1.3 Global Primary Antibody Sales Market Share by Application (2018-2029)
5.2 Global Primary Antibody Revenue by Application (2018-2029)
5.2.1 Global Primary Antibody Revenue by Application (2018-2023)
5.2.2 Global Primary Antibody Revenue by Application (2024-2029)
5.2.3 Global Primary Antibody Revenue Market Share by Application (2018-2029)
5.3 Global Primary Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bio-Rad
6.1.1 Bio-Rad Corporation Information
6.1.2 Bio-Rad Description and Business Overview
6.1.3 Bio-Rad Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bio-Rad Primary Antibody Product Portfolio
6.1.5 Bio-Rad Recent Developments/Updates
6.2 Biorbyt
6.2.1 Biorbyt Corporation Information
6.2.2 Biorbyt Description and Business Overview
6.2.3 Biorbyt Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Biorbyt Primary Antibody Product Portfolio
6.2.5 Biorbyt Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Corporation Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abcam Primary Antibody Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermo Fisher Scientific Primary Antibody Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Creative Diagnostics
6.5.1 Creative Diagnostics Corporation Information
6.5.2 Creative Diagnostics Description and Business Overview
6.5.3 Creative Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Creative Diagnostics Primary Antibody Product Portfolio
6.5.5 Creative Diagnostics Recent Developments/Updates
6.6 Novus Biologicals
6.6.1 Novus Biologicals Corporation Information
6.6.2 Novus Biologicals Description and Business Overview
6.6.3 Novus Biologicals Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novus Biologicals Primary Antibody Product Portfolio
6.6.5 Novus Biologicals Recent Developments/Updates
6.7 SouthernBiotech
6.6.1 SouthernBiotech Corporation Information
6.6.2 SouthernBiotech Description and Business Overview
6.6.3 SouthernBiotech Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SouthernBiotech Primary Antibody Product Portfolio
6.7.5 SouthernBiotech Recent Developments/Updates
6.8 Boster Bio
6.8.1 Boster Bio Corporation Information
6.8.2 Boster Bio Description and Business Overview
6.8.3 Boster Bio Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Boster Bio Primary Antibody Product Portfolio
6.8.5 Boster Bio Recent Developments/Updates
6.9 OriGene
6.9.1 OriGene Corporation Information
6.9.2 OriGene Description and Business Overview
6.9.3 OriGene Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 OriGene Primary Antibody Product Portfolio
6.9.5 OriGene Recent Developments/Updates
6.10 Genscript Biotech
6.10.1 Genscript Biotech Corporation Information
6.10.2 Genscript Biotech Description and Business Overview
6.10.3 Genscript Biotech Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Genscript Biotech Primary Antibody Product Portfolio
6.10.5 Genscript Biotech Recent Developments/Updates
6.11 Proteintech
6.11.1 Proteintech Corporation Information
6.11.2 Proteintech Primary Antibody Description and Business Overview
6.11.3 Proteintech Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Proteintech Primary Antibody Product Portfolio
6.11.5 Proteintech Recent Developments/Updates
6.12 Roche Diagnostics
6.12.1 Roche Diagnostics Corporation Information
6.12.2 Roche Diagnostics Primary Antibody Description and Business Overview
6.12.3 Roche Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Roche Diagnostics Primary Antibody Product Portfolio
6.12.5 Roche Diagnostics Recent Developments/Updates
6.13 HyTest
6.13.1 HyTest Corporation Information
6.13.2 HyTest Primary Antibody Description and Business Overview
6.13.3 HyTest Primary Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 HyTest Primary Antibody Product Portfolio
6.13.5 HyTest Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Primary Antibody Industry Chain Analysis
7.2 Primary Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Primary Antibody Production Mode & Process
7.4 Primary Antibody Sales and Marketing
7.4.1 Primary Antibody Sales Channels
7.4.2 Primary Antibody Distributors
7.5 Primary Antibody Customers
8 Primary Antibody Market Dynamics
8.1 Primary Antibody Industry Trends
8.2 Primary Antibody Market Drivers
8.3 Primary Antibody Market Challenges
8.4 Primary Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Primary Antibody Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Primary Antibody Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Primary Antibody Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Primary Antibody Sales (mg) of Key Manufacturers (2018-2023)
    Table 5. Global Primary Antibody Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Primary Antibody Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Primary Antibody Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Primary Antibody Average Price (USD/mg) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Primary Antibody, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Primary Antibody, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Primary Antibody, Product Type & Application
    Table 12. Global Key Manufacturers of Primary Antibody, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Primary Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Antibody as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Primary Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Primary Antibody Sales by Region (2018-2023) & (mg)
    Table 18. Global Primary Antibody Sales Market Share by Region (2018-2023)
    Table 19. Global Primary Antibody Sales by Region (2024-2029) & (mg)
    Table 20. Global Primary Antibody Sales Market Share by Region (2024-2029)
    Table 21. Global Primary Antibody Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Primary Antibody Revenue Market Share by Region (2018-2023)
    Table 23. Global Primary Antibody Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Primary Antibody Revenue Market Share by Region (2024-2029)
    Table 25. North America Primary Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Primary Antibody Sales by Country (2018-2023) & (mg)
    Table 27. North America Primary Antibody Sales by Country (2024-2029) & (mg)
    Table 28. North America Primary Antibody Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Primary Antibody Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Primary Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Primary Antibody Sales by Country (2018-2023) & (mg)
    Table 32. Europe Primary Antibody Sales by Country (2024-2029) & (mg)
    Table 33. Europe Primary Antibody Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Primary Antibody Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Primary Antibody Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Primary Antibody Sales by Region (2018-2023) & (mg)
    Table 37. Asia Pacific Primary Antibody Sales by Region (2024-2029) & (mg)
    Table 38. Asia Pacific Primary Antibody Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Primary Antibody Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Primary Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Primary Antibody Sales by Country (2018-2023) & (mg)
    Table 42. Latin America Primary Antibody Sales by Country (2024-2029) & (mg)
    Table 43. Latin America Primary Antibody Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Primary Antibody Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Primary Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Primary Antibody Sales by Country (2018-2023) & (mg)
    Table 47. Middle East & Africa Primary Antibody Sales by Country (2024-2029) & (mg)
    Table 48. Middle East & Africa Primary Antibody Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Primary Antibody Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Primary Antibody Sales (mg) by Type (2018-2023)
    Table 51. Global Primary Antibody Sales (mg) by Type (2024-2029)
    Table 52. Global Primary Antibody Sales Market Share by Type (2018-2023)
    Table 53. Global Primary Antibody Sales Market Share by Type (2024-2029)
    Table 54. Global Primary Antibody Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Primary Antibody Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Primary Antibody Revenue Market Share by Type (2018-2023)
    Table 57. Global Primary Antibody Revenue Market Share by Type (2024-2029)
    Table 58. Global Primary Antibody Price (USD/mg) by Type (2018-2023)
    Table 59. Global Primary Antibody Price (USD/mg) by Type (2024-2029)
    Table 60. Global Primary Antibody Sales (mg) by Application (2018-2023)
    Table 61. Global Primary Antibody Sales (mg) by Application (2024-2029)
    Table 62. Global Primary Antibody Sales Market Share by Application (2018-2023)
    Table 63. Global Primary Antibody Sales Market Share by Application (2024-2029)
    Table 64. Global Primary Antibody Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Primary Antibody Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Primary Antibody Revenue Market Share by Application (2018-2023)
    Table 67. Global Primary Antibody Revenue Market Share by Application (2024-2029)
    Table 68. Global Primary Antibody Price (USD/mg) by Application (2018-2023)
    Table 69. Global Primary Antibody Price (USD/mg) by Application (2024-2029)
    Table 70. Bio-Rad Corporation Information
    Table 71. Bio-Rad Description and Business Overview
    Table 72. Bio-Rad Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 73. Bio-Rad Primary Antibody Product
    Table 74. Bio-Rad Recent Developments/Updates
    Table 75. Biorbyt Corporation Information
    Table 76. Biorbyt Description and Business Overview
    Table 77. Biorbyt Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 78. Biorbyt Primary Antibody Product
    Table 79. Biorbyt Recent Developments/Updates
    Table 80. Abcam Corporation Information
    Table 81. Abcam Description and Business Overview
    Table 82. Abcam Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 83. Abcam Primary Antibody Product
    Table 84. Abcam Recent Developments/Updates
    Table 85. Thermo Fisher Scientific Corporation Information
    Table 86. Thermo Fisher Scientific Description and Business Overview
    Table 87. Thermo Fisher Scientific Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 88. Thermo Fisher Scientific Primary Antibody Product
    Table 89. Thermo Fisher Scientific Recent Developments/Updates
    Table 90. Creative Diagnostics Corporation Information
    Table 91. Creative Diagnostics Description and Business Overview
    Table 92. Creative Diagnostics Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 93. Creative Diagnostics Primary Antibody Product
    Table 94. Creative Diagnostics Recent Developments/Updates
    Table 95. Novus Biologicals Corporation Information
    Table 96. Novus Biologicals Description and Business Overview
    Table 97. Novus Biologicals Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 98. Novus Biologicals Primary Antibody Product
    Table 99. Novus Biologicals Recent Developments/Updates
    Table 100. SouthernBiotech Corporation Information
    Table 101. SouthernBiotech Description and Business Overview
    Table 102. SouthernBiotech Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 103. SouthernBiotech Primary Antibody Product
    Table 104. SouthernBiotech Recent Developments/Updates
    Table 105. Boster Bio Corporation Information
    Table 106. Boster Bio Description and Business Overview
    Table 107. Boster Bio Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 108. Boster Bio Primary Antibody Product
    Table 109. Boster Bio Recent Developments/Updates
    Table 110. OriGene Corporation Information
    Table 111. OriGene Description and Business Overview
    Table 112. OriGene Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 113. OriGene Primary Antibody Product
    Table 114. OriGene Recent Developments/Updates
    Table 115. Genscript Biotech Corporation Information
    Table 116. Genscript Biotech Description and Business Overview
    Table 117. Genscript Biotech Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 118. Genscript Biotech Primary Antibody Product
    Table 119. Genscript Biotech Recent Developments/Updates
    Table 120. Proteintech Corporation Information
    Table 121. Proteintech Description and Business Overview
    Table 122. Proteintech Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 123. Proteintech Primary Antibody Product
    Table 124. Proteintech Recent Developments/Updates
    Table 125. Roche Diagnostics Corporation Information
    Table 126. Roche Diagnostics Description and Business Overview
    Table 127. Roche Diagnostics Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 128. Roche Diagnostics Primary Antibody Product
    Table 129. Roche Diagnostics Recent Developments/Updates
    Table 130. HyTest Corporation Information
    Table 131. HyTest Description and Business Overview
    Table 132. HyTest Primary Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
    Table 133. HyTest Primary Antibody Product
    Table 134. HyTest Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Primary Antibody Distributors List
    Table 138. Primary Antibody Customers List
    Table 139. Primary Antibody Market Trends
    Table 140. Primary Antibody Market Drivers
    Table 141. Primary Antibody Market Challenges
    Table 142. Primary Antibody Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Primary Antibody
    Figure 2. Global Primary Antibody Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Primary Antibody Market Share by Type in 2022 & 2029
    Figure 4. Monoclonal Antibodies Product Picture
    Figure 5. Polyclonal Antibody Product Picture
    Figure 6. Global Primary Antibody Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Primary Antibody Market Share by Application in 2022 & 2029
    Figure 8. Hospital
    Figure 9. Life Sciences
    Figure 10. Laboratory
    Figure 11. Global Primary Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Primary Antibody Market Size (2018-2029) & (US$ Million)
    Figure 13. Global Primary Antibody Sales (2018-2029) & (mg)
    Figure 14. Global Primary Antibody Average Price (USD/mg) & (2018-2029)
    Figure 15. Primary Antibody Report Years Considered
    Figure 16. Primary Antibody Sales Share by Manufacturers in 2022
    Figure 17. Global Primary Antibody Revenue Share by Manufacturers in 2022
    Figure 18. The Global 5 and 10 Largest Primary Antibody Players: Market Share by Revenue in 2022
    Figure 19. Primary Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 20. Global Primary Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 21. North America Primary Antibody Sales Market Share by Country (2018-2029)
    Figure 22. North America Primary Antibody Revenue Market Share by Country (2018-2029)
    Figure 23. United States Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Canada Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Europe Primary Antibody Sales Market Share by Country (2018-2029)
    Figure 26. Europe Primary Antibody Revenue Market Share by Country (2018-2029)
    Figure 27. Germany Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. France Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. U.K. Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Italy Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Russia Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Asia Pacific Primary Antibody Sales Market Share by Region (2018-2029)
    Figure 33. Asia Pacific Primary Antibody Revenue Market Share by Region (2018-2029)
    Figure 34. China Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Japan Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. South Korea Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. India Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Australia Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. China Taiwan Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Indonesia Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Thailand Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Malaysia Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Latin America Primary Antibody Sales Market Share by Country (2018-2029)
    Figure 44. Latin America Primary Antibody Revenue Market Share by Country (2018-2029)
    Figure 45. Mexico Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Brazil Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Argentina Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Middle East & Africa Primary Antibody Sales Market Share by Country (2018-2029)
    Figure 49. Middle East & Africa Primary Antibody Revenue Market Share by Country (2018-2029)
    Figure 50. Turkey Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Saudi Arabia Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. UAE Primary Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Global Sales Market Share of Primary Antibody by Type (2018-2029)
    Figure 54. Global Revenue Market Share of Primary Antibody by Type (2018-2029)
    Figure 55. Global Primary Antibody Price (USD/mg) by Type (2018-2029)
    Figure 56. Global Sales Market Share of Primary Antibody by Application (2018-2029)
    Figure 57. Global Revenue Market Share of Primary Antibody by Application (2018-2029)
    Figure 58. Global Primary Antibody Price (USD/mg) by Application (2018-2029)
    Figure 59. Primary Antibody Value Chain
    Figure 60. Primary Antibody Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Fully-automatic Aseptic Filling Machine Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-18W3675
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3L4016
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Pharmacy Dispensing Machines Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37N3464
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Biologics Fill and Finish Services Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6U7105
Sun Feb 11 00:00:00 UTC 2024

Add to Cart